Press Release

KDA Group announces KRX updates

Thetford Mines, Quebec – July 7, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) are pleased to announce an update on the KRx dental prescriber platform (the “KRx”).

KDA Group’s collaboration with Inbay aims to set a new standard for cybersecurity for the pharmaceutical and medical sectors

Thetford Mines, Quebec – June 30, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) are pleased to announce an important new collaboration with inBay Technologies Inc. (“inBay”), an enterprisefocused cybersecurity company based in Ottawa, Canada. I

Groupe Technologique KDA completes acquisition of electronic ZRx Prescriber for United States, Europe ans United Kingdom

Thetford Mines, Quebec – May 11, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that its wholly owned subsidiary, Groupe Technologique Inc. (“KDA Techno”) has completed the acquisition of the ownership rights in the ZRx Prescriber to develop, commercialize and exploit the ZRx Prescriber in the United States, Europe and the United Kingdom, in consideration for 20,000,000 Class A shares (the “KDA Shares”) of KDA’s share capital (the “Transaction”).

KDA Technologiy Group announces KRx, it’s new integrated medical management platform for dental clinics

Thetford Mines, Quebec – April 7, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) are pleased to announce the commercialization for the Canadian market of its brand new integrated medical management platform for dental clinics called KRx dental.

KDA Group announces net earnings for the second quarter of 2021 and an update on its technology projects

Thetford Mines, Quebec – March 23, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) has released its unaudited condensed consolidated financial results for the second quarter ended January 31, 2021 (“Q2-2021”). The Corporation’s financial results, together with the management’s discussion and analysis, have been filed on SEDAR. All financial figures are in Canadian dollars unless otherwise indicated.

GROUPE TECHNOLOGIQUE KDA SIGNED AN ASSET PURCHASE AGREEMENT WITH ZOOMMED MÉDICAL FOR THE ACQUISITION OF ZRX PRESCRIBER FOR DEVELOPMENT AND EXPLOITATION IN THE UNITED STATES, EUROPE AND UNITED KINGDOM

Thetford Mines, Quebec – March 10, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce, as previously disclosed in its press release dated November 18, 2020, that its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) has entered into an asset purchase and rights assignment agreement (the “Asset Purchase Agreement”) with ZoomMed Médical Inc. (“ZoomMed Médical”) under which Tech KDA agreed to acquire, subject to certain conditions, the ZRx Prescriber and ownership rights, to develop, commercialize and exploit the ZRx Prescriber in the United States, Europe and United Kingdom, in consideration for 20,000,000 Class A shares (the “KDA Shares”) of KDA’s share capital (the “Transaction”).

KDA GROUP GRANTS STOCK OPTIONS

Thetford Mines, Quebec – February 18, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that, pursuant to its stock option plan, it has granted incentive stock options to directors, officers, employees and consultants of the Corporation to purchase up to an aggregate of 7,000,000 Class A shares (the “Common shares”). 

Groupe KDA © 2019  |  Tous droits réservés